JPH0480004B2 - - Google Patents

Info

Publication number
JPH0480004B2
JPH0480004B2 JP1091988A JP9198889A JPH0480004B2 JP H0480004 B2 JPH0480004 B2 JP H0480004B2 JP 1091988 A JP1091988 A JP 1091988A JP 9198889 A JP9198889 A JP 9198889A JP H0480004 B2 JPH0480004 B2 JP H0480004B2
Authority
JP
Japan
Prior art keywords
gastric
compound
stomach
compounds
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1091988A
Other languages
English (en)
Japanese (ja)
Other versions
JPH01313424A (ja
Inventor
Esu Gida Jasuonto
Monkobitsuku Aibo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPH01313424A publication Critical patent/JPH01313424A/ja
Publication of JPH0480004B2 publication Critical patent/JPH0480004B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP1091988A 1988-05-12 1989-04-13 胃腸運動障害治療用チアジアゾールオキサイド Granted JPH01313424A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US193025 1988-05-12
US07/193,025 US4829073A (en) 1988-05-12 1988-05-12 Thiadiazole oxides for treating gastrointestinal motility disorders

Publications (2)

Publication Number Publication Date
JPH01313424A JPH01313424A (ja) 1989-12-18
JPH0480004B2 true JPH0480004B2 (cg-RX-API-DMAC7.html) 1992-12-17

Family

ID=22711984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1091988A Granted JPH01313424A (ja) 1988-05-12 1989-04-13 胃腸運動障害治療用チアジアゾールオキサイド

Country Status (7)

Country Link
US (1) US4829073A (cg-RX-API-DMAC7.html)
EP (1) EP0341722B1 (cg-RX-API-DMAC7.html)
JP (1) JPH01313424A (cg-RX-API-DMAC7.html)
AT (1) ATE79753T1 (cg-RX-API-DMAC7.html)
DE (1) DE68902576T2 (cg-RX-API-DMAC7.html)
ES (1) ES2034484T3 (cg-RX-API-DMAC7.html)
GR (1) GR3005563T3 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
CN1063442C (zh) * 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
AU717588B2 (en) * 1996-10-24 2000-03-30 Zeria Pharmaceutical Co., Ltd. Substituted benzoylaminothiazole derivative and medicament containing the same
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors

Also Published As

Publication number Publication date
EP0341722B1 (en) 1992-08-26
EP0341722A3 (en) 1990-10-10
ATE79753T1 (de) 1992-09-15
DE68902576D1 (de) 1992-10-01
EP0341722A2 (en) 1989-11-15
JPH01313424A (ja) 1989-12-18
DE68902576T2 (de) 1993-01-21
US4829073A (en) 1989-05-09
ES2034484T3 (es) 1993-04-01
GR3005563T3 (cg-RX-API-DMAC7.html) 1993-06-07

Similar Documents

Publication Publication Date Title
KR100765579B1 (ko) 제약학적 조합물 및 이의 위장 질병의 치료를 위한 용도
AU739275B2 (en) Method of increasing bone volume using non-naturally-occurring FP selective agonists
KR0148589B1 (ko) 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
PT1789067E (pt) Utilização de hormona do crescimento secretagogo para a estimulação da motilidade do sistema gastrointestinal
WO2001054698A1 (en) Method for preventing or treating postoperative ileus
US20140315994A1 (en) Method for treating gastrointestinal disorder
EP1140054B1 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
EP0341722B1 (en) The use of thiadiazole oxides for preparing a pharmaceutical composition for treating gastrointestinal motility disorders
CN101198334B (zh) 前列腺素化合物和质子泵抑制剂用于治疗肠胃病的联合应用
CZ2001348A3 (cs) Farmaceutický prostředek
CA2102960C (en) Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
EP0069380A1 (en) 11-Deoxoglycyrrhetinic acid hydrogen maleate, process for its production, and its use as a medicine
SU1731057A3 (ru) Способ получени производных диазепинона
EP1315488A2 (en) Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
JP4078397B2 (ja) 下痢の予防及び治療剤
Scarpignato et al. Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats
EP1235565A1 (en) Use of 5ht 3 agonists for relaxing the fundus
US3574852A (en) Treating depression with the n-oxide of n-(3' - dimethylamino propyl)-iminodibenzyl
US3852454A (en) Treatment of rheumatoid arthritis
US3198705A (en) Method of inducing hypotensive and ganglionic blocking activity
WO2014034756A1 (ja) けいれん重積発作の治療用医薬組成物
JPH0132804B2 (cg-RX-API-DMAC7.html)
DE69103068T2 (de) Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.
JP2002538105A (ja) 骨体積の増加のための天然に存在しないep1選択的アゴニストの使用
RU2020931C1 (ru) Способ получения лекарственного средства для лечения язвенной болезни желудочно-кишечного тракта млекопитающих